Engvall E, Davis G E, Dickerson K, Ruoslahti E, Varon S, Manthorpe M
J Cell Biol. 1986 Dec;103(6 Pt 1):2457-65. doi: 10.1083/jcb.103.6.2457.
Monoclonal antibodies were made against a truncated form of human laminin isolated from placenta. 12 antibodies were isolated and characterized. All antibodies stained basement membranes in placenta and immunoprecipitated laminin from media of cultured choriocarcinoma cells. Three antibodies, 3E5, 4C7, and 4E10, partially blocked the neurite-promoting activity of laminin. Addition of a second antibody, goat anti-mouse IgG, caused more complete blocking of the activity. Two of the blocking antibodies, 4C7 and 4E10, reacted with epitopes within the globular domain at the end of the long arm of laminin, and the third one, 3E5, reacted at the end of the rod-like portion of the long arm adjacent to the globular domain, as shown by electron microscopy after rotary shadowing. Five nonblocking antibodies used in the same test reacted with epitopes in other domains of the molecule. Blocking antibodies 3E5 and 4E10 could be used in immunoblotting and both antibodies reacted with the same polypeptides in pepsin fragments of human laminin, the predominant polypeptides being approximately 400 kD. When a crude extract of human amnion was used as a source of intact laminin, the 4E10 antibody detected a single polypeptide of approximately 400 kD. A nonblocking antibody, 2E8, which reacted at the center of the laminin cross, reacted predominantly with a 200-kD polypeptide in human laminin fragments and exclusively with a 200-kD polypeptide in amnion extract and in rat laminin. Our results with human laminin match the results by Edgar, D., R. Timpl, and H. Thoenen, 1984, EMBO (Eur. Mol. Biol. Organ.) J., 3:1463-1468, in which the neurite-promoting activity of mouse laminin resides at the end of the long arm, which is also the site for heparin binding. However, since the active fragments of human laminin did not bind to heparin, the neurite-promoting site should be different from the heparin-binding site. Our results further suggest that the neurite-promoting site may be contained in or close to the 400-kD component of laminin.
制备了针对从胎盘中分离出的截短型人层粘连蛋白的单克隆抗体。分离并鉴定了12种抗体。所有抗体均能对胎盘中的基底膜进行染色,并从培养的绒毛膜癌细胞培养基中免疫沉淀层粘连蛋白。三种抗体,3E5、4C7和4E10,部分阻断了层粘连蛋白的促神经突生长活性。添加第二种抗体山羊抗小鼠IgG后,对该活性的阻断更完全。两种阻断抗体4C7和4E10与层粘连蛋白长臂末端球状结构域内的表位发生反应,第三种抗体3E5在长臂杆状部分末端与球状结构域相邻处发生反应,旋转阴影电子显微镜观察结果表明了这一点。在同一试验中使用的五种非阻断抗体与该分子其他结构域中的表位发生反应。阻断抗体3E5和4E10可用于免疫印迹免疫印迹,两种抗体均与人层粘连蛋白胃蛋白酶片段中的相同多肽发生反应,主要多肽约为400kD。当使用人羊膜粗提物作为完整层粘连蛋白的来源时,4E10抗体检测到一条约400kD的单一多肽。一种非阻断抗体2E8在层粘连蛋白十字交叉的中心发生反应,在人层粘连蛋白片段中主要与一条200kD的多肽发生反应,在羊膜提取物和大鼠层粘连蛋白中仅与一条200kD的多肽发生反应。我们关于人层粘连蛋白的研究结果与Edgar、D.、R. Timpl和H. Thoenen在1984年发表于《欧洲分子生物学组织杂志》(EMBO J.)第3卷第1463 - 1468页的研究结果相符,其中小鼠层粘连蛋白的促神经突生长活性位于长臂末端,该部位也是肝素结合位点。然而,由于人层粘连蛋白的活性片段不与肝素结合,因此促神经突生长位点应与肝素结合位点不同。我们的结果进一步表明,促神经突生长位点可能包含在层粘连蛋白的400kD组分中或与之接近。